Swiss Re Ltd
Source: SEC Form 13F · as of Mar 2026Swiss Re Ltd holds 21 biotech & pharma companies tracked by BioSniper, totaling $755K in value as of Mar 2026 (SEC Form 13F).
Companies held
21
Total value held
$755K
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 161 | $148K |
| JNJJOHNSON & JOHNSON | 523 | $128K |
| MRKMerck & Co., Inc. | 537 | $65K |
| ABBVAbbVie Inc. | 208 | $45K |
| PMPhilip Morris International Inc | 248 | $41K |
| ABTABBOTT LABORATORIES | 391 | $40K |
| GILDGILEAD SCIENCES, INC. | 251 | $35K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 107 | $29K |
| BMYBRISTOL MYERS SQUIBB CO | 470 | $29K |
| MCKMcKesson Corporation | 32 | $28K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 61 | $27K |
| PFEPFIZER INC | 776 | $22K |
| REGNREGENERON PHARMACEUTICALS, INC. | 25 | $19K |
| BIIBBIOGEN INC. | 90 | $17K |
| CORCencora Inc. | 50 | $16K |
| AMGNAMGEN INC | 44 | $15K |
| IDXXIDEXX LABORATORIES INC /DE | 20 | $11K |
| IQVIQVIA Holdings Inc. | 65 | $11K |
| INSMINSMED Inc | 62 | $10K |
| ALNYALNYLAM PHARMACEUTICALS, INC. | 30 | $10K |
| GMOptec International, Inc. | 125 | $9K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.